Index.php
From Thikipedia
| Line 1: | Line 1: | ||
| - | + | The researchers reviewed four drugs: Allegra, Arava, Amaryl and Zithromax. In the second half 2005, each of these drugs come to an end of patent protection. Their simple equivalents were obtained instead at an average factor of 87 % within 30 days of the equivalents supply at pharmacies. | |
| - | + | The investigation was organized by Medco Health Solutions Inc. based in Frankin Lakes, which can be the greatest drug benefit management company in U.S. The business deals for low rates of prescription drug with respect to its customers. | |
| - | + | In line with the study, Zithromax, the blockbuster of Pfizer Inc. with its annual sales of $1.85 million was rapidly substituted at pharmacies by equivalent at a 90 percent rate right after it lost its patent protection in November. | |
| - | + | The research authors mentioned the alternative of Zithromax, an for respiratory infections, as proof that more and more doctors order simple versions of manufacturer drugs more quickly, even when it's about alleged acute treatment drugs, such as Zithromax. | |
| - | + | The truly good news is why these four common medicines are only the start. With numerous popular drugs expected to move off patent next many years, we must see considerable prescription drug prices savings - explained a senior vice president, Dr. Glen Stettin. | |
| - | + | A speaker at Medco, Ann Smith reported that more than 70 brand drugs, including 19 blockbusters, are losing their patent protection next five years - with total yearly sales of $45 billion. | |
| - | + | If Medcos study shows a development, in the coming years customers, employers and insurance firms will save vast amounts of dollars in prescription drug - Smith said. | |
| - | + | The data met with enthusiastic response from consumer groups. | |
| - | + | We hope the pattern continues. Its good for people, revealed Bill Vaughan, senior coverage analyst for an group, Consumer Union, located in Washington, D.C. | |
| - | + | Vaughan stated that past fears in regards to the safety and effectiveness of common drugs have apparently started to fade away as society has become more concerned with rapid increase of health-care costs. | |
| + | |||
| + | The FDA approves these generic drugs simply because they have been established just as safe and effective as their manufacturer counterparts, nevertheless, you spend a portion of the price, Vaughan reported. We think that is very good and can save consumers literally billions of dollars within the next several years. | ||
| + | |||
| + | At the same time, large pharmaceutical companies have stated that their brand name drugs won't be replaced by replicas as insurers and doctors realize that the brand name drugs guarantee greater treatment and in consequence - cut costs. | ||
| + | |||
| + | Hank McKinnell, Pfizer Chairman used that argument throughout last session with experts in New York. | ||
| + | |||
| + | In the event that you dont such as the high cost of healthcare, try the high cost of vomiting, McKinnell encouraged. [ Activity] | ||
Revision as of 19:07, 20 December 2012
The researchers reviewed four drugs: Allegra, Arava, Amaryl and Zithromax. In the second half 2005, each of these drugs come to an end of patent protection. Their simple equivalents were obtained instead at an average factor of 87 % within 30 days of the equivalents supply at pharmacies.
The investigation was organized by Medco Health Solutions Inc. based in Frankin Lakes, which can be the greatest drug benefit management company in U.S. The business deals for low rates of prescription drug with respect to its customers.
In line with the study, Zithromax, the blockbuster of Pfizer Inc. with its annual sales of $1.85 million was rapidly substituted at pharmacies by equivalent at a 90 percent rate right after it lost its patent protection in November.
The research authors mentioned the alternative of Zithromax, an for respiratory infections, as proof that more and more doctors order simple versions of manufacturer drugs more quickly, even when it's about alleged acute treatment drugs, such as Zithromax.
The truly good news is why these four common medicines are only the start. With numerous popular drugs expected to move off patent next many years, we must see considerable prescription drug prices savings - explained a senior vice president, Dr. Glen Stettin.
A speaker at Medco, Ann Smith reported that more than 70 brand drugs, including 19 blockbusters, are losing their patent protection next five years - with total yearly sales of $45 billion.
If Medcos study shows a development, in the coming years customers, employers and insurance firms will save vast amounts of dollars in prescription drug - Smith said.
The data met with enthusiastic response from consumer groups.
We hope the pattern continues. Its good for people, revealed Bill Vaughan, senior coverage analyst for an group, Consumer Union, located in Washington, D.C.
Vaughan stated that past fears in regards to the safety and effectiveness of common drugs have apparently started to fade away as society has become more concerned with rapid increase of health-care costs.
The FDA approves these generic drugs simply because they have been established just as safe and effective as their manufacturer counterparts, nevertheless, you spend a portion of the price, Vaughan reported. We think that is very good and can save consumers literally billions of dollars within the next several years.
At the same time, large pharmaceutical companies have stated that their brand name drugs won't be replaced by replicas as insurers and doctors realize that the brand name drugs guarantee greater treatment and in consequence - cut costs.
Hank McKinnell, Pfizer Chairman used that argument throughout last session with experts in New York.
In the event that you dont such as the high cost of healthcare, try the high cost of vomiting, McKinnell encouraged. [ Activity]
